Ethyl Acetate

Ethyl Acetate

SCHEMBL6902039

CCC(=O)OC.CCOC(C)=O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.67
HSD17B10 Q99714 2/20 0.67
LMNA P02545 1/20 0.67
GAA P10253 3/20 0.50
MGAM O43451 2/20 0.50
SI P14410 2/20 0.50
MGAM2 Q2M2H8 2/20 0.50
SOAT1 P35610 1/20 0.44
TSHR P16473 4/20 0.43
TRPA1 O75762 1/20 0.41
ALOX15 P16050 1/20 0.39
MAPT P10636 1/20 0.36
NAAA Q02083 1/20 0.35
GLO1 Q04760 1/20 0.35
CYP1A2 P05177 1/20 0.35
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Propionate SCHEMBL31567655 0.88 ALDH1A1 (0.64) ALDH1A1HSD17B10LMNAGAAMGAM
Ethyl Propionate SCHEMBL10714742 0.85 GAA (0.62) ALDH1A1HSD17B10LMNAGAAMGAM
Ethyl Propionate SCHEMBL9211473 0.85 ALDH1A1 (0.74) ALDH1A1HSD17B10LMNAGAAMGAM
Ethyl Acetate SCHEMBL498804 0.85 ALDH1A1 (0.82) ALDH1A1HSD17B10LMNAGAAMGAM
Ethyl Acetate SCHEMBL6295337 0.85 ALDH1A1 (0.82) ALDH1A1HSD17B10LMNAGAAMGAM
Ethyl Acetate SCHEMBL19252753 0.84 GAA (0.68) ALDH1A1HSD17B10LMNAGAAMGAM
Ethyl Acetate SCHEMBL1561858 0.82 ALDH1A1 (0.78) ALDH1A1HSD17B10LMNAGAAMGAM
Ethyl Acetate SCHEMBL6728709 0.82 ALDH1A1 (0.78) ALDH1A1HSD17B10LMNAGAAMGAM
Ethyl Acetate SCHEMBL27636781 0.82 ALDH1A1 (0.61) ALDH1A1HSD17B10LMNAGAAMGAM
Acetone SCHEMBL28995064 0.82 MGAM (0.55) ALDH1A1HSD17B10LMNAGAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150112037-A1 PROCESS FOR THE PRODUCTION OF METHYL METHACRYLATE Mitsubishi Chemical UK Limited (GB) 2015-04-23 US claimed
EP-4029593-A1 DEHYDRATION OF WATER CONTAINING SOURCE OF FORMALDEHYDE, AND A METHOD FOR PRODUCING AN ETHYLENICALLY UNSATURATED CARBOXYLIC ESTER Mitsubishi Chemical UK Limited (GB) 2022-07-20 EP disclosed
US-10793448-B2 Dehydration of water containing source of formaldehyde, and a method for producing an ethylenically unsaturated carboxylic ester LUCITE INTERNATIONAL UK LIMITED (GB) 2020-10-06 US disclosed
US-10093559-B2 Dehydration of water containing source of formaldehyde, and a method for producing an ethylenically unsaturated carboxylic ester LUCITE INTERNATIONAL UK LIMITED (GB) 2018-10-09 US disclosed
US-9816115-B2 Process for the production of methyl methacrylate LUCITE INTERNATIONAL UK LIMITED (GB) 2017-11-14 US disclosed
US-20150112037-A1 PROCESS FOR THE PRODUCTION OF METHYL METHACRYLATE Mitsubishi Chemical UK Limited (GB) 2015-04-23 US disclosed
US-20150053616-A1 Dehydration of Water Containing Source of Formaldehyde, and a Method for Producing an Ethylenically Unsaturated Carboxylic Ester Mitsubishi Chemical UK Limited (GB) 2015-02-26 US disclosed
EP-2814596-A1 DEHYDRATION OF WATER CONTAINING SOURCE OF FORMALDEHYDE, AND A METHOD FOR PRODUCING AN ETHYLENICALLY UNSATURATED CARBOXYLIC ESTER Lucite International UK Limited (GB) 2014-12-24 EP disclosed
WO-2013122268-A1 DEHYDRATION OF WATER CONTAINING SOURCE OF FORMALDEHYDE, AND A METHOD FOR PRODUCING AN ETHYLENICALLY UNSATURATED CARBOXYLIC ESTER MITSUBISHI RAYON CO., LTD. (JP) 2013-08-22 WO disclosed
CN-1756849-A Modulation of protein functionality DECIPHERA PHARMACEUTICALS LLC (US) 2006-04-05 CN disclosed
US-20040071867-A1 Composition and method for rejuvenating weathered polymeric materials STUART ALAN (US) 2004-04-15 US disclosed
US-6669991-B2 Applying to surface of vinyl siding composition consisting of organic solvents having specified solubility parameter, optional diluents and stabilizers DONNA M. STUART, TRUSTOR AND TRUSTEE OF THE CECIL B. STUART AND DONNA STUART REVOCABLE LIVING TRUST 2003-12-30 US disclosed
US-20030180452-A1 Method and composition for rejuvenating weathered polymeric materials DONNA M. STUART, TRUSTOR AND TRUSTEE OF THE CECIL B. STUART AND DONNA STUART REVOCABLE LIVING TRUST 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10093559-B2 Dehydration of water containing source of formaldehyde, and a method for producing an ethylenically unsaturated carboxylic ester ADH1A, AQP1, SAT1 ALDH1A1 1157/4885HSD17B10 1870/4885LMNA 955/4885
US-10793448-B2 Dehydration of water containing source of formaldehyde, and a method for producing an ethylenically unsaturated carboxylic ester ADH1A, AQP1, SAT1 ALDH1A1 1157/4885HSD17B10 1870/4885LMNA 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.